"What does the general public not understand the most about clinical trials?" is the question we posed to three industry professionals at DIA 2023.
"What does the general public not understand the most about clinical trials?" is the question we posed to three industry professionals. And their answers span only a few of the challenges that remain in patient education and knowledge about the clinical research enterprise.
Advertisement
In this video, Kenneth Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development and Founder, Board Chair, CISCRP; Janice Chang, CEO of TransCelerate BioPharma, and Greg Ball, Safety Data Scientist and founder, ASAP Process Consulting present their views on the topic.
